-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $62

Benzinga·05/06/2026 16:44:40
Listen to the news
Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $48 to $62.